InvestorsHub Logo

Ubertino

10/23/13 9:23 PM

#75683 RE: changes_iv #75680

If I was big pharma I would be doing my best to trump Cides with a better drug. That will not be easy! Cides are just about as good as it gets., Perhaps a universal Flu vaccine or a universal viral anything vaccine will do it but I do not foresee those for years yet. I only just recently became aware of that Oxford supported universal flu vaccine in the UK at trial stages now.

If big pharma expects to get access to ViriCides with a fat wallet they may be in for a shock.

My inclination for any collaboration would be to go with some mutually advantageous little pharma in the UK and/or China.

Echo20

10/23/13 11:33 PM

#75688 RE: changes_iv #75680

CHANGESIV

We also have two candidates, FluCide and DengueCide, with unprecedented and consistent test data results in efficacy (pre-IND) and now we know they have "low toxicity".

Well put.

Now NNVC has over 5000 tests showing no or low toxicity. Most impressive.

Some people on this board have been here through most of those 5000 tests. Each was a big step forward.

Offers would be very interesting.

Will the stockholders have any say so in the offers and acceptance?

Echo20